2024 Annual Conference, 20th - 21st June, Glasgow
University Hospital Birmingham NHS Trust
Dr Shobhit Baijal is a Consultant Medical Oncologist based at The University Hospital Birmingham NHS Trust. He obtained a BSc Honours in immunology and cell pathology from University College London, before graduating with a medical degree from St Bartholomew’s Medical School in 2001. Dr Baijal returned to the Midlands to complete his general medical and oncology training and took up post as Consultant Medical Oncologist in September 2011.
He actively treats lung and colorectal cancer patients at the Heartlands, Good Hope and Solihull sites. He specialises in all forms of cancer drug treatment including chemotherapy, immuno-oncology, precision oncology and chemo-embolisation.
Dr Baijal has a large clinical trial portfolio and is UK Chief Investigator and Principle Investigator for national and international clinical trials. He is at the forefront of the clinical utility of liquid biopsy in managing lung and colorectal cancer patients and has several studies underway in this context. He has numerous publications and regularly presents at regional, national and international cancer meetings. He is on the BTOG Steering Committee also sits on the Roy Castle Lung Cancer Foundation advisory panel.